Efletirizine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B6C301298G. European Medicines Agency schedules Efletirizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06467MIG. Efletirizine generally arises in the molecular formula C21H24F2N2O3. The term EFLETIRIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, no. 3, 1995, list 35.) EFLETIRIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule efletirizine under HS 29335995 and SITC 51576. As of Q4 2014, EFLETIRIZINE remains the US FDA Preferred Term for this commodity. Efletirizine bears US NLM identifiers UMLS ID C0893504 and NCI Concept Code C73048. SMILES: FC1CCC(C(N2CCN(CC2)CCOCC(=O)O)C2CCC(F)CC2)CC1.